Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

CT-388

A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus

Roche · Phase 2 · Completed · Enrollment 447

NCT06628362

ArmPopulationDoseWeeksEstimandWeight change
Arm 1: PlaceboObesity + T2Dn/r48n/rn/r
Arm 2: Enicepatide Dose Level 1 (Low)Obesity + T2Dn/r48n/rn/r
Arm 3: Enicepatide Dose Level 2Obesity + T2Dn/r48n/rn/r
Arm 4: Enicepatide Dose Level 3Obesity + T2Dn/r48n/rn/r
Arm 5: Enicepatide Dose Level 4 (High)Obesity + T2Dn/r48n/rn/r